Lawyers are beginning to take notice of product liability cases dealing with the blood thinner Xarelto. Since its release to market in 2012, more than 50 cases have been filed against the manufacturer, Bayer, and marketing company, Jansen Pharmaceuticals. Though Xarelto side effects are listed, many consumers were not made aware of the severe side effects that may result in taking this drug.
The drug is prescribed to patients to stop blood from clotting and reduce the risk of stroke. However, there is no antidote to the drug, which has caused victims cases of severe bleeding. The severe bleeding associated with Xarelto includes:
- Bleeding from the rectum.
- Bleeding from the brain.
- Bleeding from the abdomen or intestine.
This severe bleeding has caused patients extended hospital stays, and in some cases, death. Patients and the loved ones helping them through these unexpected side effects have suffered severe emotional trauma.
Similar to the case of the blood thinner Pradaxa, that saw victims receive over $650 million in damages, lawyers are fighting for victims of Xarelto and their families to receive damages as well. As the number of victims continues to rise, the U.S. District Court of Louisiana is handling these cases as multi-district litigations.
If the following is true of your Xarelto client, you likely have a solid case:
- They cared for a loved one suffering from Xarelto side effects for an extended period of time.
- They incurred extensive bills from medical care for themselves or a loved one who suffered the effects of Xarelto.
- Lost pay or job security due to extended medical care from Xarelto side effects.
- Suffered emotional stress caring for or losing a loved one due to Xarelto side effects.
- Desire to hold the manufacturer or marketing company responsible for doing minimal research before releasing a dangerous drug to market.
- Desire to hold to the manufacturer or marketing company responsible for releasing a dangerous drug to market with minimal safety warning.
As of right now, Xarelto cases continue to come in with upwards of 50 cases currently being reviewed and many more expected to be brought to court.